ZNF724

mutation — cross-omics
Cross-omicsMUTATION → DRUGCell-linePairwise association · TCGA cohorts

Across TCGA cell cohorts, ZNF724 mutation is significantly associated with the drug of many other genes, with 14 significant associations in total. LARGE_INTESTINE shows the largest number of these associations.

The most reproducible ZNF724-associated genes across cancer lineages are PRT062607, AZD5991, and 123829. Each is linked with ZNF724 in more than 1 cancer types. Because this analysis shows association rather than direction, both ZNF724-to-partner and partner-to-ZNF724 results are reported.

Each partner links to its own Q-omics profile.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (ZNF724→partner) and Y-score (partner→ZNF724) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LARGE_INTESTINEPRT062607 →+0.650+2.777.009.03031
LARGE_INTESTINEAZD5991 →+0.927+2.649.015.04631
LARGE_INTESTINE123829 →+0.718+2.649.012.04631
LARGE_INTESTINEKRAS (G12C) Inhibitor-12 →+0.598+2.646.016.04731
LARGE_INTESTINEAZD5438 →+0.525+2.777.033.03821
LARGE_INTESTINETeniposide →+0.610+2.649.021.04621
Each partner links to its Q-omics profile. Showing the 6 strongest of 14 associations by consensus.

Exploration